Farkas Vánky - Concepedia

Author

Farkas Vánky

Karolinska Institutet ORCID

Also Known As

Barbro Larson, F B Vanky, F Vanky, F Vánky, F. Vanky, F. VÁNKY, F. Vànky, F. Vánky, FARKAS VÁNKY, Farkas B. Vánky

161

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Karolinska Institutet Sophiahemmet Hospital Karolinska University Hospital Linköping University Hospital Linköping University

About

Farkas Vánky is an author at Karolinska Institutet specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	41	1.9K
2	Public Health	6	6	220
3	Allergy	4	4	91
4	Education	1	1	11
5	Health Sciences	1	1	11

Farkas Vánky

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
LYMPHOPENIA AND CHANGE IN DISTRIBUTION OF HUMAN B AND T LYMPHOCYTES IN PERIPHERAL BLOOD INDUCED BY IRRADIATION FOR MAMMARY CARCINOMA Jan Stjernswärd, Farkas Vánky, Mikael Jondal, The Lancet Malignant Blood DisorderImmunologyLymphatic SystemPathologyBreast Cancer	1972	463
Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia Eva Klein, Farkas Vánky, Hannah Ben‐Bassat, International Journal of Cancer	1976	426
Expression of the adhesion molecule ICAM-1 and major histocompatibility complex class I antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitro Farkas Vánky, Ping Wang, Manuel E. Patarroyo, Cancer Immunology Immunotherapy HistocompatibilityAutologous LymphocytesAdhesion Molecule Icam-1Autoimmune DiseaseHuman Tumor Cells	1990	137
Human tumour—lymphocyte interaction <i>in vitro</i>. V. Comparison of the reactivity of tumour‐infiltrating, blood and lymph‐node lymphocytes with autologous tumour cells B. M. Vose, Farkas Vánky, E. Klein International Journal of Cancer V. ComparisonImmunologyImmune RegulationImmunophenotypingTumour Stimulation Assays	1977	119
Natural cytotoxicity in man: activity of lymph node and tumor‐infiltrating lymphocytes B. M. Vose, Farkas Vánky, Shmuel Argov, European Journal of Immunology	1977	110
Lymphocyte cytotoxicity against autologous tumour biopsy cells in humans B. M. Vose, Farkas Vánky, Eva Klein International Journal of Cancer ImmunologyPathologyImmunotherapyTumor BiologyBenign Tumours	1977	103
MHC class‐I‐restricted auto‐tumor‐specific CD4<sup>+</sup>CD8 <sup>−</sup>T‐cell clones established from autologous mixed lymphocyte‐tumor‐cell culture (MLTC) P. Wang, Farkas Vánky, E. Klein International Journal of Cancer	1992	86
Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor. Farkas Vánky, T Gorsky, Y Gorsky, The Journal of Experimental Medicine ImmunologyPathologyImmunotherapyTumor BiologyHematological Malignancy	1982	85
Specificity of auto‐tumor cytotoxicity exerted by fresh, activated and propagated human t lymphocytes Farkas Vánky, Eva Klein International Journal of Cancer	1982	81
Mixed venous oxygen saturation predicts short- and long-term outcome after coronary artery bypass grafting surgery: a retrospective cohort analysis Jonas Holm, Erik Håkanson, Farkas Vánky, British Journal of Anaesthesia Venous DiseaseCardiovascular DiseaseLong-term OutcomeSurgeryTissue Oxygenation	2011	68

Page 1